{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:24:26Z","timestamp":1767824666423,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s12325-009-0039-0","type":"journal-article","created":{"date-parts":[[2009,6,26]],"date-time":"2009-06-26T09:07:07Z","timestamp":1246007227000},"page":"588-599","source":"Crossref","is-referenced-by-count":16,"title":["Long-acting risperidone: a review of its role in the treatment of bipolar disorder"],"prefix":"10.1007","volume":"26","author":[{"given":"David E.","family":"Kemp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Canan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin I.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,26]]},"reference":[{"key":"39_CR1","volume-title":"Manic-Depressive Illness","author":"F.K. Goodwin","year":"2007","unstructured":"Goodwin FK, Jamison KR. Manic-Depressive Illness. 2nd edition. New York, NY: Oxford University Press; 2007.","edition":"2"},{"key":"39_CR2","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMsa043266","volume":"352","author":"R.C. Kessler","year":"2005","unstructured":"Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 2005;352:2515\u20132523.","journal-title":"N Engl J Med"},{"key":"39_CR3","first-page":"495","volume":"72","author":"C.J. Murray","year":"1994","unstructured":"Murray CJ, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ. 1994;72:495\u2013509.","journal-title":"Bull World Health Organ"},{"key":"39_CR4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v68n0811","volume":"68","author":"G.E. Simon","year":"2007","unstructured":"Simon GE, Bauer MS, Ludman EJ, Operskalski BH, Unutzer J. Mood symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression. J Clin Psychiatry. 2007;68:1237\u20131245.","journal-title":"J Clin Psychiatry"},{"key":"39_CR5","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/archpsyc.58.9.844","volume":"58","author":"U. Osby","year":"2001","unstructured":"Osby U, Brandt L, Correla N, et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58:844\u2013850.","journal-title":"Arch Gen Psychiatry"},{"key":"39_CR6","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1176\/ps.2006.57.10.1482","volume":"57","author":"B.J. Miller","year":"2006","unstructured":"Miller BJ, Paschall CB3rd, Svendsen DP. Mortality and medical comorbidity among patients with serious mental illness. Psychiatr Serv. 2006;57:1482\u20131487.","journal-title":"Psychiatr Serv"},{"key":"39_CR7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-0327(01)00377-9","volume":"68","author":"F. Angst","year":"2002","unstructured":"Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34\u201338 years. J Affect Disord. 2002;68:167\u2013181.","journal-title":"J Affect Disord"},{"key":"39_CR8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1399-5618.2006.00432.x","volume":"6","author":"L.N. Yatham","year":"2006","unstructured":"Yatham LN, Kennedy SH, O\u2019Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord. 2006;6:721\u2013739.","journal-title":"Bipolar Disord"},{"key":"39_CR9","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1176\/appi.ajp.160.7.1263","volume":"160","author":"M. Tohen","year":"2003","unstructured":"Tohen M, Ketter TA, Zarate CA, et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry. 2003;160:1263\u20131271.","journal-title":"Am J Psychiatry"},{"key":"39_CR10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4088\/JCP.v67n0414","volume":"67","author":"P.E. Keck Jr.","year":"2006","unstructured":"Keck PE,Jr., Calabrese JR, McQuade RD, et al. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry. 2006;67:626\u2013637.","journal-title":"J Clin Psychiatry"},{"key":"39_CR11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-5618.2006.00314.x","volume":"8","author":"M. Sajatovic","year":"2006","unstructured":"Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord. 2006;8:232\u2013231.","journal-title":"Bipolar Disord"},{"key":"39_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","volume":"47","author":"P. Seeman","year":"2002","unstructured":"Seeman P. Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002;47:27\u201338.","journal-title":"Can J Psychiatry"},{"key":"39_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2003.11.001","volume":"70","author":"M. Eerdekens","year":"2004","unstructured":"Eerdekens M, Van Hove I, Remmerie B, Mannaert E. Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia. Schizophr Res. 2004;70:91\u2013100.","journal-title":"Schizophr Res"},{"key":"39_CR14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1176\/appi.ajp.160.6.1125","volume":"160","author":"J.M. Kane","year":"2003","unstructured":"Kane JM, Eerdekens M, Lindenmayer JP, Keith SJ, Lesem M, Karcher K. Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic. Am J Psychiatry. 2003;160:1125\u20131132.","journal-title":"Am J Psychiatry"},{"key":"39_CR15","unstructured":"Risperdal Consta (risperidone) long-acting injection. Prescribing information. Titusville, NJ: Ortho-McNeil-Janssen Pharmaceuticals, Inc.; 2008."},{"key":"39_CR16","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","volume":"161","author":"R.M. Hirschfeld","year":"2004","unstructured":"Hirschfeld RM, Keck PEJr, Kramer M, et al. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am J Psychiatry. 2004;161:1057\u20131065.","journal-title":"Am J Psychiatry"},{"key":"39_CR17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2004.06.003","volume":"15","author":"A.B. Smulevich","year":"2005","unstructured":"Smulevich AB, Khanna S, Eerdekens M, Karcher K, Kramer M, Grossman F. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Eur Neuropsychopharmacol. 2005;15:75\u201384.","journal-title":"Eur Neuropsychopharmacol"},{"key":"39_CR18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1399-5618.2007.00468.x","volume":"6","author":"L.A. Smith","year":"2007","unstructured":"Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D. Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials. Bipolar Disord. 2007;6:551\u2013560.","journal-title":"Bipolar Disord"},{"key":"39_CR19","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","volume":"159","author":"G.S. Sachs","year":"2002","unstructured":"Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry. 2002;159:1146\u20131154.","journal-title":"Am J Psychiatry"},{"key":"39_CR20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1192\/bjp.182.2.141","volume":"182","author":"L.N. Yatham","year":"2003","unstructured":"Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran. Mood stabilizers plus risperidone or placebo in the treatment of acute mania. Br J Psychiatry. 2003;182:141\u2013147.","journal-title":"Br J Psychiatry"},{"key":"39_CR21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.187.3.229","volume":"187","author":"S. Khanna","year":"2005","unstructured":"Khanna S, Vieta E, Lyons B, Grossman F, Eerdekens M, Kramer M. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry. 2005;187:229\u2013234.","journal-title":"Br J Psychiatry"},{"key":"39_CR22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.jcp.0000231609.91144.00","volume":"26","author":"H.A. Savas","year":"2006","unstructured":"Savas HA, Mehmet Y, Murat EO. Use of long-acting risperidone in the treatment of bipolar patients. J Clin Psychopharmacol. 2006;26:530\u2013531.","journal-title":"J Clin Psychopharmacol"},{"key":"39_CR23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.pnpbp.2007.04.017","volume":"31","author":"C. Han","year":"2007","unstructured":"Han C, Lee M, Pae C, Ko Y, Patkar AA, Jung I. Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1219\u20131223.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"39_CR24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/YIC.0b013e3282f2b4c5","volume":"23","author":"R.N. Malempati","year":"2008","unstructured":"Malempati RN, Bond DJ, Yatham LN. Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients. Int Clin Psychopharmacol. 2008;23:88\u201394.","journal-title":"Int Clin Psychopharmacol"},{"key":"39_CR25","first-page":"1","volume":"23","author":"E. Vieta","year":"2008","unstructured":"Vieta E, Nieto E, Autet A, et al. A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone. World J Biol Psychiatry. 2008;23:1\u20136.","journal-title":"World J Biol Psychiatry"},{"key":"39_CR26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0447.2007.01059.x","volume":"116","author":"L.N. Yatham","year":"2007","unstructured":"Yatham LN, Fallu A, Binder CE. A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder. Acta Psychiatr Scand Suppl. 2007;116:50\u201356.","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"39_CR27","doi-asserted-by":"crossref","unstructured":"Kujawa M, Turner N, Turkoz I, et al. Frequently relapsing bipolar disorder: evidence for an effective treatment. Presented at: 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders; Montreux, Switzerland; February 3\u20137, 2008.","DOI":"10.1016\/j.schres.2007.12.005"},{"key":"39_CR28","unstructured":"Johnson & Johnson Pharmaceutical Research & Development, LLC. 2008. Clinical Trials website. A study of the safety and efficacy of injectable risperidone in the prevention of bipolar mood episodes (NCT00132678). Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00132678 . Accessed October 15, 2008."},{"key":"39_CR29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4088\/JCP.v63n0502","volume":"635","author":"J. Scott","year":"2002","unstructured":"Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry. 2002;635:384\u2013390.","journal-title":"J Clin Psychiatry"},{"key":"39_CR30","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0149-2918(08)80062-8","volume":"30","author":"F.D. Gianfrancesco","year":"2008","unstructured":"Gianfrancesco FD, Sajatovic M, Rajagopalan K, Wang RH. Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorder. Clin Ther. 2008;30:1358\u20131374.","journal-title":"Clin Ther"},{"issue":"suppl.1","key":"39_CR31","first-page":"189","volume":"5","author":"H.J. Freyberger","year":"2002","unstructured":"Freyberger HJ, Eerdekens M, Duchesne I, et al. Patient satisfaction with their medication during longacting risperidone injection. Int J Neuropsychopharmacol. 2002;5(suppl. 1):189. Abstract.","journal-title":"Int J Neuropsychopharmacol"},{"key":"39_CR32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4088\/JCP.08m04427","volume":"70","author":"D.M. Taylor","year":"2009","unstructured":"Taylor DM, Fischetti C, Sparshatt A, Thomas A, Bishara D, Cornelius V. Risperidone long-acting injection: a prospective 3-year analysis of its use in clinical practice. J Clin Psychiatry. 2009;70:196\u2013200.","journal-title":"J Clin Psychiatry"},{"key":"39_CR33","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","volume":"667","author":"T. Suppes","year":"2005","unstructured":"Suppes T, Dennehy EB, Hirschfeld RM, et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. 2005;667:870\u2013886.","journal-title":"J Clin Psychiatry"},{"key":"39_CR34","unstructured":"Young A, McElroy S, Olausson B, et al. Quetiapine monotherapy up to 52 weeks in patients with bipolar depression: continuation phase data from EMBOLDEN I & II. Presented at: 21st ENCP Conference; Barcelona, Spain; August 30\u2013September 3, 2008."},{"key":"39_CR35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2008.06.001","volume":"109","author":"E. Vieta","year":"2008","unstructured":"Vieta E, Suppes T, Eggans I, et al. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord. 2008;109:251\u2013263.","journal-title":"J Affect Disord"},{"key":"39_CR36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","volume":"166","author":"T. Suppes","year":"2009","unstructured":"Suppes T, Vieta E, Liu S, et al. Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127). Am J Psychiatry. 2009;166:476\u2013488.","journal-title":"Am J Psychiatry"},{"key":"39_CR37","unstructured":"Brecher M, Anderssen H, Paulsson P. Quetiapine in the maintenance treatment of bipolar I disorder: combined data from two long-term, phase III studies (NR 3-007). New Research Abstracts. Presented at: Annual Meeting of the American Psychiatric Association 2008; Washington, DC, USA; May 3, 2008."},{"key":"39_CR38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","volume":"11","author":"L.N. Yatham","year":"2009","unstructured":"Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11:225\u2013255.","journal-title":"Bipolar Disord"},{"key":"39_CR39","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","volume":"68","author":"P.E. Keck Jr.","year":"2007","unstructured":"Keck PEJr., Calabrese JR, McIntyre RS, et al. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry. 2007;68:1480\u20131491.","journal-title":"J Clin Psychiatry"},{"key":"39_CR40","unstructured":"Kemp DE, Calabrese JR, Van-Tran Q, et al. Components of metabolic syndrome in patients enrolled in a clinical trial of aripiprazole for the maintenance treatment of bipolar disorder. Presented at: American College of Neuropsychopharmacology Annual Meeting; Boca Raton, FL; Dec. 9-13, 2007."},{"key":"39_CR41","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1176\/appi.ajp.2007.05081484","volume":"1653","author":"C.D. Schneck","year":"2008","unstructured":"Schneck CD, Miklowitz DJ, Miyahara S, et al. The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2008;1653:370\u2013377.","journal-title":"Am J Psychiatry"},{"key":"39_CR42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.163.2.217","volume":"1632","author":"R.H. Perlis","year":"2006","unstructured":"Perlis RH, Ostacher MJ, Patel, JK, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2006;1632:217\u2013224.","journal-title":"Am J Psychiatry"},{"key":"39_CR43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1034\/j.1600-0447.2003.00126.x","volume":"108","author":"L. Tondo","year":"2003","unstructured":"Tondo L, Hennen J, Baldessarini RJ. Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand. 2003;108:4\u201314.","journal-title":"Acta Psychiatr Scand"},{"key":"39_CR44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.psc.2005.01.001","volume":"28","author":"L.N. Yatham","year":"2005","unstructured":"Yatham LN. Atypical antipsychotics for bipolar disorder. Psychiatr Clin North Am. 2005;28:325\u2013347.","journal-title":"Psychiatr Clin North Am"},{"key":"39_CR45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1176\/appi.ajp.163.2.210","volume":"163","author":"A.A. Nierenberg","year":"2006","unstructured":"Nierenberg AA, Ostacher MJ, Calabrese JR. Treatmen-tresistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry. 2006;163:210\u2013216.","journal-title":"Am J Psychiatry"},{"key":"39_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.2006.00810.x","volume":"114","author":"D. Taylor","year":"2006","unstructured":"Taylor D. Risperidone long-acting injection practice: more questions than answers? Acta Psychiatr Scand. 2006;114:1\u20132.","journal-title":"Acta Psychiatr Scand"},{"key":"39_CR47","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4088\/JCP.v68n0808","volume":"68","author":"Y.M. Bai","year":"2007","unstructured":"Bai YM, Ting Chen T, Chen JY, et al. Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective single-blind pharmacokinetic study. J Clin Psychiatry. 2007;68:1218\u20131225.","journal-title":"J Clin Psychiatry"},{"key":"39_CR48","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1176\/appi.ajp.2008.08060967","volume":"165","author":"J.R. Calabrese","year":"2008","unstructured":"Calabrese JR, Kemp DE. Bipolar drug development: are we getting closer to the real world? Am J Psychiatry. 2008;165:1234\u20131236.","journal-title":"Am J Psychiatry"},{"key":"39_CR49","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1176\/appi.ajp.2008.08050756","volume":"165","author":"L. Sikich","year":"2008","unstructured":"Sikich L, Frazier JA, McClellan J, et al. Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizoaffective disorder: findings from the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study. Am J Psychiatry. 2008;165:1420\u20131431.","journal-title":"Am J Psychiatry"},{"key":"39_CR50","unstructured":"Clinical Trials website. A study to evaluate the effectiveness and safety of extended-release (ER) paliperidone compared with placebo in delaying the recurrence of symptoms in bipolar I disorder. Available at: http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00490971?term=paliperidone+ER+bipolar&rank=3 . Accessed December 21, 2008."},{"key":"39_CR51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1742-1241.2008.01900.x","volume":"63","author":"L. Citrome","year":"2009","unstructured":"Citrome L. Olanzapine pamoate: a stick in time? A review of the efficacy and safety profile of a new depot formulation of a second-generation antipsychotic. Int J Clin Pract. 2009;63:140\u2013150.","journal-title":"Int J Clin Pract"},{"key":"39_CR52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/00023210-200418020-00005","volume":"18","author":"T.S. Harrison","year":"2004","unstructured":"Harrison TS, Goa KL. Long-acting risperidone: a review of its use in schizophrenia. CNS Drugs. 2004;18:113\u2013132.","journal-title":"CNS Drugs"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-009-0039-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-009-0039-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-009-0039-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T20:11:30Z","timestamp":1685045490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-009-0039-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1007\/s12325-009-0039-0","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}